Company: ADZCF
Filing Date: 2025-06-17
Form Type: 424B2
Source: 0000950103-25-007465
Chunk: 18

Company: DEUTSCHE BANK AKTIENGESELLSCHAFT
Filing Date: 2025-06-17
Form: 424B2
Chunk 18
---
 stable            
 financially than large-capitalization companies and may depend on a small number of key personnel, making them more vulnerable to loss                 
 of personnel. Small-capitalization companies are often subject to less analyst coverage and may be in early, and less predictable, periods             
 of their corporate existences. Small-capitalization companies tend to have lower revenues, less diverse product lines, smaller shares                  
 of their target markets, fewer financial resources and fewer competitive strengths than large-capitalization companies. These companies                
 may also be more susceptible to adverse developments related to their products or services.                                                            |

Risks Relating to Conflicts of Interest

| · | Trading and Other Transactions by Us, UBS or                                                                                                    
 Our or Its Affiliates in the Equity and Equity Derivative Markets May Impair the Value of the Securities — We                                   
 or our affiliates expect to hedge our exposure from the Securities by entering into equity and equity derivative transactions, such as          
 over-the-counter options, futures or exchange-traded instruments with one or more hedge counterparties, which will include UBS or its           
 affiliates. We, UBS or our or its affiliates may also engage in trading in instruments linked or related to the Underlying on a                 
 regular basis as part of our or their general broker-dealer and other businesses, for proprietary accounts, for other accounts under management 
 or to facilitate transactions for customers, including block transactions. Such trading and hedging activities may adversely affect the         
 value of the Underlying and, therefore, make it less likely that you will receive a positive return on your investment in the Securities.       
 It is possible that we, UBS or our or its affiliates could receive substantial returns from these hedging and trading activities while          
 the value of the Securities declines. We, UBS or our or its affiliates may also issue or underwrite other                                       
 securities or financial or derivative instruments with returns linked or related to the Underlying. To the extent that we, UBS or our           
 or its affiliates serve as issuer, agent or underwriter for such securities or financial or derivative instruments, our, UBS’                   
 or our or its affiliates’ interests with respect to such products may be adverse to those of the holders of the Securities.                     
 Introducing competing products into the marketplace in this manner could adversely affect the value of the Underlying and the value             
 of the Securities. Any of the foregoing activities described in this paragraph may reflect trading strategies that differ from, or are          
 in direct opposition to, investors’ trading and investment strategies related to the Securities. Furthermore